ScrutarSign up free

Gossamer Bio, Inc. (GOSS)

SEC filings, insider trading & institutional ownership from EDGAR.

NasdaqHealth CarePharmaceuticals
Institutions
33
$19.28B held

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →

No filings are available yet.

Top holders

13F & 13D/G · latest quarter

All →
HolderFiledValue
D. E. Shaw & Co., Inc.Aug 14, 2026$6.74B
AQR CAPITAL MANAGEMENT LLCAug 14, 2026$2.57B
RENAISSANCE TECHNOLOGIES LLCAug 13, 2026$1.91B
Vanguard Capital ManagementAug 13, 2026$1.55B
BlackRock, Inc.Aug 7, 2026$1.26B

GOSS's filings are public. The insight is one click away.

Scrutar's AI reads every GOSS filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze GOSS filingsNo credit cardAI reports included on the free plan

Never miss a GOSS filing.

Get an email when GOSS files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Aug 30, 2026Source: SEC EDGAR.